Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-21-000013 General Corporate
Debt relative to revenue 9th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.debt_to_revenue
47.43% · OPTIONAL · VALID
Capex intensity 82th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.00% · OPTIONAL · VALID
Operating cash generation 64th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
17.21% · OPTIONAL · VALID
Share-count growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.shares_outstanding
-0.77% · CORE · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-9.32% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 18th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
11.77% · OPTIONAL · VALID
Gross margin 18th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.gross_margin
37.50% · CORE · VALID
Operating margin 9th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.operating_margin
1.92% · CORE · VALID
R&D intensity 55th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.18% · OPTIONAL · VALID
SBC intensity 45th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.70% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 202.79%
Current 47.43%
Delta -155.35% Capex Intensity Increased
Previous 1.61%
Current 2.00%
Delta 0.39% Cash Generation Decreased
Previous 22.23%
Current 17.21%
Delta -5.01% Dilution Decreased
Previous 0.57%
Current -0.77%
Delta -1.35% Growth Decreased
Previous -9.02%
Current -9.32%
Delta -0.30% Inventory Pressure Decreased
Previous 46.91%
Current 11.77%
Delta -35.14% Margin Decreased
Previous 38.64%
Current 37.50%
Delta -1.15% Profitability Increased
Previous -27.80%
Current 1.92%
Delta 29.72% R And D Intensity Increased
Previous 2.06%
Current 2.18%
Delta 0.11% Sbc Intensity Decreased
Previous 0.77%
Current 0.70%
Delta -0.07% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.